|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
|
US6699497B1
(en)
*
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
|
ES2211151T3
(es)
|
1998-08-19 |
2004-07-01 |
Skyepharma Canada Inc. |
Dispersiones acuosas inyectables de propofol.
|
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
|
EP2158903A3
(en)
|
1998-12-18 |
2010-04-14 |
ALZA Corporation |
Transparent Transdermal Nicotine Delivery Devices
|
|
AU3536799A
(en)
*
|
1999-04-26 |
2000-11-10 |
Lead Chemical Co., Ltd. |
Percutaneous preparations containing oxybutynin
|
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
|
US6562368B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6957924B1
(en)
|
2000-02-14 |
2005-10-25 |
Johnson & Johnson Consumer Companies, Inc. |
Textured film devices
|
|
US6607739B1
(en)
|
2000-02-14 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Dispensing article
|
|
US6783294B2
(en)
|
2000-02-14 |
2004-08-31 |
Johnson & Johnson Consumer Companies, Inc. |
Solid cleanser holder
|
|
US6436428B1
(en)
|
2000-03-21 |
2002-08-20 |
Enhance Pharmaceuticals, Inc. |
Device and method for treating urinary incontinence in females
|
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
JP2003531157A
(ja)
|
2000-04-26 |
2003-10-21 |
ワトソン ファーマシューティカルズ， インコーポレイテッド |
オキシブチニン治療に関連した有害な経験の最小化
|
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
|
WO2002054996A2
(en)
*
|
2000-10-23 |
2002-07-18 |
Euro Celtique Sa |
Terazosin transdermal device and methods
|
|
BR0207955A
(pt)
*
|
2001-03-07 |
2004-02-25 |
Hisamitsu Pharmaceutical Co |
Agente de emplastro
|
|
DE10237057A1
(de)
*
|
2002-08-09 |
2004-03-25 |
Grünenthal GmbH |
Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
|
|
JP4354678B2
(ja)
*
|
2002-08-28 |
2009-10-28 |
久光製薬株式会社 |
貼付剤
|
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
|
ATE319426T1
(de)
*
|
2003-11-11 |
2006-03-15 |
Mattern Udo |
Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
|
|
US20050234024A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Clarke David E |
Materials and methods for the treatment of ulcerative colitis
|
|
JP2005325165A
(ja)
*
|
2004-05-12 |
2005-11-24 |
Three M Innovative Properties Co |
１００℃以下の温度で溶融塗布可能なヨウ素含有ホットメルト粘着剤および該粘着剤を用いた医療用粘着シート製品
|
|
US20070082039A1
(en)
*
|
2004-10-18 |
2007-04-12 |
Jones Gerald S Jr |
Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids
|
|
US8246977B2
(en)
|
2004-10-21 |
2012-08-21 |
Durect Corporation |
Transdermal delivery systems
|
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
CN101340884A
(zh)
|
2005-10-19 |
2009-01-07 |
曼尼·马纳舍·辛格尔 |
用于治疗多汗症的方法
|
|
WO2007095147A2
(en)
*
|
2006-02-13 |
2007-08-23 |
Aveva Drug Delivery Systems |
Adhesive preparation comprising sufentanil and methods of using the same
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
BRPI0621655A2
(pt)
*
|
2006-05-08 |
2011-12-20 |
Teikoku Seiyaku Kk |
preparação para a absorção percutánea de uma droga antidemência básica
|
|
ES2379117T3
(es)
|
2006-05-16 |
2012-04-20 |
Knopp Neurosciences, Inc. |
Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
|
|
WO2008040488A1
(en)
|
2006-10-04 |
2008-04-10 |
M & P Patent Aktiengesellschaft |
Controlled release delivery system for nasal application of neurotransmitters
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
CA2681110A1
(en)
*
|
2007-03-14 |
2008-09-18 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
|
KR20110071064A
(ko)
*
|
2008-08-19 |
2011-06-28 |
크놉 뉴로사이언시스 인코포레이티드 |
(ｒ)-프라미펙솔을 사용하는 조성물 및 방법
|
|
CA2733265A1
(en)
*
|
2008-09-30 |
2010-04-08 |
Teikoku Pharma Usa, Inc. |
Transdermal extended-delivery donepezil compositions and methods for using the same
|
|
EP2355806A2
(en)
*
|
2008-11-14 |
2011-08-17 |
Profimed s.r.o. |
Non-aqueous colloidal formulation
|
|
US8920392B2
(en)
|
2009-05-05 |
2014-12-30 |
Watson Laboratories, Inc. |
Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
|
DE102009022915A1
(de)
*
|
2009-05-27 |
2010-12-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
|
|
RU2012101792A
(ru)
*
|
2009-06-19 |
2013-07-27 |
Нопп Ньюросайенсиз, Инк. |
Композиции и способы для лечения бокового амиотрофического склероза
|
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
|
WO2012096866A2
(en)
|
2011-01-10 |
2012-07-19 |
Inverseon, Inc. |
Use of beta-adrenergic inverse agonists for smoking cessation
|
|
AR086400A1
(es)
|
2011-05-13 |
2013-12-11 |
Trimel Pharmaceuticals Corp |
Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
|
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
|
TW201338813A
(zh)
*
|
2011-12-12 |
2013-10-01 |
洛曼治療系統股份有限公司 |
經皮遞送系統
|
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
|
US9074972B2
(en)
|
2012-05-16 |
2015-07-07 |
Dionex Corporation |
Surrogate addition device and a method of analyte concentration
|
|
CN103919754B
(zh)
*
|
2013-01-15 |
2018-11-06 |
江苏康倍得药业股份有限公司 |
奥昔布宁药物组合物及其应用
|
|
EP3473615B1
(en)
|
2013-02-28 |
2022-01-19 |
Journey Medical Corporation |
Glycopyrrolate salts
|
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
|
US9006462B2
(en)
|
2013-02-28 |
2015-04-14 |
Dermira, Inc. |
Glycopyrrolate salts
|
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
|
EP3838271B1
(en)
|
2013-07-12 |
2025-09-03 |
Areteia Therapeutics, Inc. |
Treating elevated levels of eosinophils and/or basophils
|
|
ES2813674T3
(es)
|
2013-08-13 |
2021-03-24 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
|
|
CA2921381A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
|
KR101827980B1
(ko)
*
|
2013-10-07 |
2018-02-13 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
|
|
BR112016006848A2
(pt)
|
2013-10-07 |
2017-08-01 |
Teikoku Pharma Usa Inc |
métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
|
|
CA2924233C
(en)
|
2013-10-07 |
2018-10-23 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
|
|
CN104666279A
(zh)
*
|
2013-11-28 |
2015-06-03 |
上海现代药物制剂工程研究中心有限公司 |
载药的三维网状立体构型的透皮给药制剂及其制备方法
|
|
EP4122460A1
(en)
|
2015-01-09 |
2023-01-25 |
Chase Pharmaceuticals Corporation |
Oxybutynin transdermal therapeutic system combination
|
|
WO2017117554A1
(en)
|
2015-12-30 |
2017-07-06 |
Corium International, Inc. |
Systems and methods for long term transdermal administration
|
|
AU2017281789B2
(en)
|
2016-06-23 |
2023-04-13 |
Corium, LLC. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
|
US10300025B2
(en)
|
2016-07-27 |
2019-05-28 |
Corium, Inc. |
Donepezil transdermal delivery system
|
|
WO2018022818A1
(en)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Memantine transdermal delivery systems
|
|
TWI764951B
(zh)
|
2016-10-31 |
2022-05-21 |
美商帝國製藥美國股份有限公司 |
用於處理疼痛之右美托咪啶經皮遞送裝置
|
|
EP4729123A2
(en)
|
2017-04-24 |
2026-04-22 |
Alto Neuroscience, Inc. |
Compositions comprising pramipexole and a 5ht3 antagonist for use in treating depression
|
|
AU2018307792B2
(en)
*
|
2017-07-26 |
2024-08-08 |
Corium, LLC. |
Transdermal delivery system with a microporous membrane having solvent-filled pores
|
|
US11173132B2
(en)
|
2017-12-20 |
2021-11-16 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
|
WO2023069778A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Georgetown University |
Non-invasive and passive transdermal drug delivery patch for parkinson's disease
|